Ettrich, T. J., Uhl, W., Kornmann, M., Algul, H., Friess, H., Koenig, A., Gress, T. M., Gallmeier, E., Lutz, M. P., Wille, K., Schimanski, C. C., Kunzmann, V., Waldschmidt, D. T., Daum, S., Held, S., Perkhofer, L., Schuhbaur, J., Tempero, M. A., Reinacher-Schick, A. C., Seufferlein, T. (2025). Five-year outcomes of perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (the NEONAX trial): A randomized phase II trial of the AIO pancreatic cancer group.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4193